Kato, H., Nangaku, M., Hirakata, H., Wada, T., Hayashi, T., Sato, H., . . . Narita, I. (2017). Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial). Clin Exp Nephrol.
Chicago Style CitationKato, Hideki, et al. "Erratum To: Rationale and Design of OBservational Clinical Research In Chronic Kidney Disease Patients With Renal Anemia: Renal ProGnosis in Patients With Hyporesponsive Anemia To Erythropoiesis-stimulating Agents, DarbepoetiN Alfa (BRIGHTEN Trial)." Clin Exp Nephrol 2017.
Cita MLAKato, Hideki, et al. "Erratum To: Rationale and Design of OBservational Clinical Research In Chronic Kidney Disease Patients With Renal Anemia: Renal ProGnosis in Patients With Hyporesponsive Anemia To Erythropoiesis-stimulating Agents, DarbepoetiN Alfa (BRIGHTEN Trial)." Clin Exp Nephrol 2017.